XPEL amends bylaws to designate Nevada courts as exclusive forum for disputes

XPEL is set to unveil its groundbreaking color-changing paint protection film at the upcoming SEMA show, a significant event for automotive enthusiasts and industry professionals. This innovative product not only offers protection for vehicles but also allows owners to change the color of their car at will, combining aesthetics with functionality. The debut at SEMA highlights XPEL's commitment to pushing the boundaries of automotive technology, making it a must-see for anyone interested in the future of car customization.

Navan has made significant updates to its charter and bylaws as it prepares for its upcoming IPO. These amendments are crucial as they align the company's governance with public market standards, enhancing investor confidence. By entering into exchange agreements, Navan is positioning itself strategically for a successful public offering, which could provide the necessary capital for future growth and expansion.

As the SNAP shutdown continues into November, around 42 million Americans are at risk of losing their benefits. This situation is critical as many families rely on these funds for essential needs. It's important for recipients to know their options and seek support during this challenging time while the courts are expected to intervene.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the stability of the sector.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the sector's resilience.

Aviat Networks reported a remarkable 21.4% increase in revenue for Q1 FY2026, surpassing market expectations. This growth highlights the company's strong performance and positive outlook in the telecommunications sector.

Stoke Therapeutics recently presented its Q3 2025 results, showcasing impressive revenue growth alongside significant advancements in its clinical programs. The company's progress highlights its commitment to developing innovative therapies, making it a key player in the biotechnology sector.

Amgen has reported a 12% increase in revenue for Q3 2025, prompting the company to raise its guidance due to strong product performance. This positive trend highlights the effectiveness of their strategies and the growing demand for their offerings.

Corsair's Q3 2025 slides indicate a strong growth trajectory, despite missing earnings forecasts. The company is navigating challenges while showcasing resilience in its performance.